UAlberta has a strong record of pioneering research discoveries and innovations, many of which have spawned new companies and products. Our company creation record goes back over 50 years, when UAlberta spinoffs R&L Molecular Research (1962) and Raylo Chemicals (1966) helped launch Alberta’s biotech economy. Forty years later, what began as Raylo Chemicals was acquired by in 2006 by global biotech company Gilead Sciences. Gilead chose to remain and expanded its Edmonton footprint and payroll, which is now over 400 high tech employees.
Transferring discoveries, knowledge and innovations out of the university is just one way our research is helping shape the future, improving quality of life, driving economic diversity and serving the public who help fund that research.
From idea, to market, to you
Research creates the knowledge required to innovate and create new solutions and technologies. Commercialization is one way new discoveries make their way to you. Spinoff companies are formed to transfer research discoveries directly, while UAlberta research discoveries can also be licensed to a non UAlberta company to develop and market.
Our dedicated commercialization arm and business accelerator is TEC Edmonton—a non-profit joint venture between UAlberta and the Edmonton Economic Development Corporation. Since 2013, it has been ranked one of the world's top university business incubators. In 2018 it was named world’s 3rd best university linked business incubator. Learn more, visit TEC Edmonton.
Company growth and success. Not just creation
We don’t just focus on creating companies—that’s the “easier” part. We focus on helping new companies succeed via various entrepreneurial supports and resources. The evidence our approach is working is demonstrated by the fact we have 130+ research driven spin-offs still operational.